cancer diagnostics
Scope
Date
~
-
Bio & Pharma
PCL’s diagnostic kit measures concentration of COVID-19 antibodies
PCL Inc., a South Korean in vitro diagnostics device maker, plans to bring two test kits – one that simultaneously detects COVID-19 and influenza infe...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
LabGenomics, NGeneBio join forces for US market
Korea's two diagnostics companies, NGeneBio Co. and LabGenomics Co., signed a memorandum of understanding (MOU) on Thursday to cooperate in the fiel...
Dec 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's SD Biosensor to supply diagnostics kits to Japan in H2
SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...
Aug 18, 2022 (Gmt+09:00)
-
Food & Beverage
Starbucks Korea conducts voluntary recall on giveaway items
Starbucks Korea, owned by South Korean retail juggernaut E-Mart, conducts a voluntary recall of its line of summer travel bags, following health c...
Aug 11, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SD Biosensor seeks more M&As, to build diagnostic kit plant in US
SD Biosensor Inc., the world's largest COVID-19 test kit seller, is seeking additional merger and acquisition targets in the US following its recent...
Jul 10, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SD Biosensor, SJL Partners to acquire Meridian Bioscience for $1.53 bn
SD Biosensor Inc., the world's largest COVID-19 test kit seller, and private equity firm SJL Partners LLC are jointly acquiring Meridian Bioscience ...
Jul 07, 2022 (Gmt+09:00)
language -
Healthcare
Precision to supply to Antech for US vet diagnostics market entry
A number of veterinary diagnostics companies are struggling to differentiate themselves in the global market. According to Grand View Research Inc.,...
Jul 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Pet health: Korean genetic testing firms' new target market
South Korean direct-to-consumer (DTC) genetic testing companies are rushing to the veterinary diagnostics market where they see greater potential gr...
Jun 20, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Biotech
JW Bioscience in pancreatic cancer biomarker deal with Immunovia
JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...
Sep 15, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Biotech
IMB Dx eyes platform to detect stage 1 cancer with single draw of blood
IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...
Jul 22, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
Korean chipmakers
Chip shortage hits Korea’s COVID-19 diagnostic device manufacturers
The global chip shortage is impacting South Korea’s COVID-19 test device makers. They are paying up to 10 times the normal price of semiconduc...
Jun 07, 2021 (Gmt+09:00)
-
Construction & Planning
Hyundai CE, Amazon develop AI-based equipment diagnosis technology
Hyundai Construction Equipment Co. (Hyundai CE), an affiliate of Hyundai Heavy Industries Holdings Co., said on May 17 that it has jointly developed...
May 17, 2021 (Gmt+09:00)
-
In vitro diagnostics
Samsung hands over diagnostics business to local bio firm
Samsung Electronics Co. has agreed to hand over the business rights for its in vitro diagnostics (IVD) unit to a South Korean bio company as part ...
Dec 07, 2020 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand